NEW YORK, July 18, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Indivior PLC (“Indivior” or the “Company”) (NASDAQ: INDV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
Month: July 2024
NEW YORK, July 18, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Dril-Quip, Inc. (“Dril-Quip” or the “Company”) (NYSE: DRQ). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, July 18, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of MediaAlpha, Inc. (“MediaAlpha” or the “Company”) (NYSE: MAX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, July 18, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Bridger Aerospace Group Holdings, Inc. (“Bridger” or the “Company”) (NASDAQ: BAER). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext….
NEW YORK, July 18, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Brookfield Business Partners L.P. (“Brookfield” or the “Company”) (NYSE: BBU). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980….
NEW YORK, July 18, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of ServiceNow, Inc. (“ServiceNow” or the “Company”) (NYSE: NOW). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, July 18, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Elanco Animal Health Incorporated (“Elanco” or the “Company”) (NYSE: ELAN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, July 18, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Moderna, Inc. (“Moderna” or the “Company”) (NASDAQ: MRNA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, July 18, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. (“PTC” or the “Company”) (NASDAQ: PTCT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK,, July 18, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Owens & Minor, Inc. (“OMI” or the “Company”) (NYSE: OMI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…